Search

everythinglearnresearchcommunity

for

Search:↓

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Nanocarriers can make acne treatments more effective and gentle on the skin.

The nano-carrier makes etoposide safer and more effective against lung cancer.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

New acne treatments show promise as alternatives to traditional therapies.

The new treatment effectively heals drug-resistant bacteria-infected wounds.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Nanotechnology can effectively deliver antimicrobial peptides for treating infections.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Solid lipid nanoparticles are promising for delivering various drugs and improving treatment effectiveness.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

Solid lipid nanoparticles are promising for safe and effective drug delivery but need more research for clinical use.

Enzyme injections can effectively treat epidermoid cysts without surgery.

Injection lipolysis effectively reduces small fat deposits and should be done with care and proper patient selection.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Five FDA-approved drugs may help block COVID-19 virus entry.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Deoxycholic acid is FDA-approved for reducing submental fat, but its mechanisms are not fully understood.